Restore Vision Raises 1.3 Billion Yen in Pre-Series B Round
NQ Score
84/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Restore Vision Inc., a biotech startup aiming for visual restoration via gene therapy, has raised 1.3 billion yen in a Pre-Series B round. Combined with previous equity and AMED grants, their total funding has exceeded 5.8 billion yen, accelerating the global clinical development of their lead pipeline, RV-001.